Cargando…

ASPP2 expression predicts the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization

Transcatheter arterial chemoembolization (TACE) induces ischemia-hypoxia and local chemotherapy-induced cytotoxicity which destroys cancerous cells. However, some patients do not respond to TACE. The causes for such a lack of response remain unclear. Recent studies have revealed that self-regulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Jiaren, Tan, Zhongjun, Pan, Xiaoqi, Meng, Feijian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918402/ https://www.ncbi.nlm.nih.gov/pubmed/33680119 http://dx.doi.org/10.3892/etm.2021.9828

Ejemplares similares

Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Nhu, Quan M, et al.
Publicado: (2016)

Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Hatanaka, Takeshi, et al.
Publicado: (2018)

Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma
por: Yang, De-jun, et al.
Publicado: (2016)

Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma
por: Murata, Satoru, et al.
Publicado: (2013)

Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma
por: Firouznia, Kavous, et al.
Publicado: (2014)

Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
por: Grover, Inderpreet, et al.
Publicado: (2014)

The radiological prognostic factors of transcatheter arterial chemoembolization to hepatocellular carcinoma
por: Lee, Shou-Wu, et al.
Publicado: (2022)

Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: Kim, Sungkeun, et al.
Publicado: (2020)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
por: Kobayashi, Saito, et al.
Publicado: (2020)

Analysis of factors affecting the prognosis of transcatheter arterial chemoembolization for hepatitis B-related hepatocellular carcinoma
por: Cun, Jiangping, et al.
Publicado: (2021)

I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma
por: Gao, Fu-Lei, et al.
Publicado: (2022)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
por: Cai, Rong, et al.
Publicado: (2017)

Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2021)

Serum T Cell Immunoglobulin Mucin 3 Predicts Worse Prognosis in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization
por: Li, Jun, et al.
Publicado: (2022)

Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma
por: Zhou, Yanming, et al.
Publicado: (2013)

Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenib
por: Fu, Sirui, et al.
Publicado: (2016)

Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Lin, Ming-Tzer, et al.
Publicado: (2010)

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma
por: NISHIKAWA, HIROKI, et al.
Publicado: (2012)

Spinal Cord Ischemia Secondary to Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: Bazine, Aziz, et al.
Publicado: (2014)

Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma
por: Liu, Chen, et al.
Publicado: (2016)

Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
por: Takano, Michitoshi, et al.
Publicado: (2016)

The feasibility of transcatheter arterial chemoembolization following radiation therapy for hepatocellular carcinoma
por: Hamada, Mostafa, et al.
Publicado: (2021)

Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis
por: Liu, Xin, et al.
Publicado: (2023)

Hepatocellular carcinoma associated with budd-chiari syndrome: imaging features and transcatheter arterial chemoembolization
por: Liu, Feng-Yong, et al.
Publicado: (2013)

Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)
por: Wei, Yanyan, et al.
Publicado: (2018)

Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone
por: Hassanin, Taha M, et al.
Publicado: (2021)

Serum YKL-40 Independently Predicts Outcome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
por: Zhu, Cheng-Bao, et al.
Publicado: (2012)

Apparent Diffusion Coefficient Can Predict Therapy Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization
por: Drewes, Ralph, et al.
Publicado: (2022)

Hepatocellular Carcinoma More Than 3 cm in Diameter: A Systematic Review of Transcatheter Arterial Chemoembolization Plus Percutaneous Ethanol Injection versus Transcatheter Arterial Chemoembolization Alone
por: Wang, Shiying, et al.
Publicado: (2013)

Diffusion Kurtosis Imaging for Assessing the Therapeutic Response of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
por: Yuan, Zhen-Guo, et al.
Publicado: (2020)

Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy
por: An, Chao, et al.
Publicado: (2021)

The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
por: Lee, Shou-Wu, et al.
Publicado: (2021)

Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization: Difficulties on Imaging Follow-up
por: Yu, Jeong-Sik
Publicado: (2005)

Improved Efficacy of Transcatheter Arterial Chemoembolization Using Warmed Miriplatin for Hepatocellular Carcinoma
por: Yasui, Daisuke, et al.
Publicado: (2014)

Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma
por: Huang, Yao-Kuang, et al.
Publicado: (2017)

Combination therapy of transcatheter arterial chemoembolization with axitinib for the treatment of inoperable hepatocellular carcinoma
por: Nouso, Kazuhiro, et al.
Publicado: (2020)

Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
por: Zou, Jixue, et al.
Publicado: (2019)

Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Yi, Jun Ho, et al.
Publicado: (2021)

Cure of Hepatoblastoma Through Transcatheter Arterial Chemoembolization
por: Yang, Tianyou, et al.
Publicado: (2017)

Predicting the prognosis of hepatocellular carcinoma with the treatment of transcatheter arterial chemoembolization combined with microwave ablation using pretreatment MR imaging texture features
por: Liu, Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_29muaotarvkfego25nnoi9ud17